Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has announcements × Colorectal Neoplasms × nilotinib × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Recurrence 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Neoplastic Processes 1 Myeloproliferative Disorders 1 Leukemia 1 Hematologic Diseases 1 Bronchiolitis Obliterans Syndrome 1 Bone Marrow Diseases 1

Interventions

Cetuximab 5 Bevacizumab 4 pembrolizumab 3 Leucovorin 3 Irinotecan 3 Fluorouracil 3 trifluridine tipiracil drug combination 2 trastuzumab deruxtecan 2 encorafenib 2 Oxaliplatin 2 HMPL-013 2 tucatinib 1 sotorasib 1 regorafenib 1 pralsetinib 1 larotrectinib 1 entrectinib 1 binimetinib 1 adagrasib 1 Trastuzumab 1 Panitumumab 1 Nivolumab 1 Levoleucovorin 1 Ipilimumab 1 IFL protocol 1 Capecitabine 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡